Pictet Asset Management (Switzerland)’s Caribou Biosciences CRBU Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$7.69M	Sell	1,809,261 -256,915	-12%	-$1.15M	0.01%	679
2023 Q1	$11M	Sell	2,066,176 -487,702	-19%	-$3.04M	0.01%	600
2022 Q4	$16M	Sell	2,553,878 -737,020	-22%	-$6.56M	0.02%	496
2022 Q3	$34.7M	Buy	3,290,898 +601,671	+22%	+$5.61M	0.05%	333
2022 Q2	$14.6M	Buy	2,689,227 +4,679	+0.2%	+$35.8K	0.02%	519
2022 Q1	$24.6M	Buy	2,684,548 +768,117	+40%	+$8.09M	0.03%	452
2021 Q4	$28.9M	Sell	1,916,431 -48,276	-2%	-$939K	0.03%	448
2021 Q3	$46.9M	Buy	+1,964,707	New	+$48M	0.05%	347

Other funds holding CRBU

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RCMU

Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EWM

Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s CRBU Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) reduced its Caribou Biosciences (CRBU) stake by 12% in Q2 2023, selling an estimated $1.15M and leaving 1,809,261 shares worth $7.69M. The position accounts for 0.01% of the portfolio, ranked #679.

Pictet Asset Management (Switzerland) first reported a position in CRBU in Q3 2021 and has held it in 8 quarters since. The position peaked at $46.9M in Q3 2021. 121 funds tracked by Wall St. Rank hold CRBU as of Q2 2023.

Pictet Asset Management (Switzerland) held 1,809,261 shares of Caribou Biosciences worth $7.69M as of Q2 2023.
Pictet Asset Management (Switzerland) sold 256,915 Caribou Biosciences shares in Q2 2023, an estimated $1.15M.
Caribou Biosciences made up 0.01% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #679 holding.
Pictet Asset Management (Switzerland) first reported a position in Caribou Biosciences in Q3 2021 and has held it in 8 quarters since.
Pictet Asset Management (Switzerland)'s Caribou Biosciences position peaked at $46.9M in Q3 2021.
121 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.